Skip to main content
SpringerLink
Log in

Association Between Nuclear Receptor Coactivator 1 and Stem Cell Signaling Pathway and Identification of Natural NCOA1 Inhibitors: An in-silico Study

  • Chapter
  • First Online:
Phytochemistry: An in-silico and in-vitro Update

Abstract

Nuclear receptor coactivator 1 (NCOA1) is overexpressed in various cancer and is associated with disease resistance and its poor prognosis. miRNAs are the short stretch of noncoding nucleotide sequence responsible for RNA silencing and post-transcriptional gene regulation. Deregulated expression of miRNAs is associated with carcinogenesis. Present study focuses on the evolution of the NCOA1, identification of miRNAs (and their associated pathways) occupied in the regulation of NCOA1, and natural inhibitors of the protein by using various online and offline computational tools such as, molecular evolutionary genetics analysis (MEGA6) tool, DIANA-mirPathv3 software and Maestro 9.6 (Schrödinger Inc) respectively. The phylogenetic analyses of different isolates of nuclear receptor coactivator show that humans formed a separate clade. Five miRNAs (has-mir-186-3p, has-mir-27a-3p, has-mir-27b-3p, has-mir-7-2-3p, and has-mir-374a-5p) occupied in the regulation of NCOA1 protein were found to highly associated with cancer stem cell pathway. Excellent Dock Score of kaempferol and hesperidin analogs was found against NCOA1 active site. The interactions pattern underlined the involvement of lipophilic, electrostatic, hydrogen bonding, π-cation stacking, and π-π stacking mode of interaction at the active site. Thus analog of kaempferol and hesperidin may contribute to developing as a potential agent for cancer chemotherapy and resistance. Association of recognized miRNAs with NCOA1 protein strengthens its role in cancer resistance through stem cell signaling pathways.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Anzick SL, Kononen J, Walker RL, Azorsa D, Tanner MM, Guan X, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 1997;277(5328):965–8.

    Article  CAS  PubMed  Google Scholar 

  • Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;1:289–300.

    Google Scholar 

  • Bhanot A, Sharma R, Noolvi MN. Natural sources as potential anti-cancer agents: A review. Int J Phytomed. 2011;3(1):09–26.

    Google Scholar 

  • Calderón-Montaño JM, Burgos-Morón E, Pérez-Guerrero C, López-Lázaro M. A review on the dietary flavonoid kaempferol. Mini Rev Med Chem. 2011;11(4):298–344.

    Article  PubMed  Google Scholar 

  • Carotenuto F, Albertini MC, Coletti D, Vilmercati A, Campanella L, Darzynkiewicz Z, Teodori L. How diet intervention via modulation of DNA damage response through microRNAs may have an effect on cancer prevention and aging, an in silico study. Int J Mol Sci. 2016;17(5):1–21.

    Article  CAS  Google Scholar 

  • Chen X, Liu Z, Xu J. The cooperative function of nuclear receptor coactivator 1 (NCOA1) and NCOA3 in placental development and embryo survival. Mol Endocrinol. 2010;24(10):1917–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cherigo L, Lopez D, Martinez-Luis S. Marine natural products as breast cancer resistance protein inhibitors. Mar Drugs. 2015;13(4):2010–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005;100(1–2):72–9.

    Article  CAS  PubMed  Google Scholar 

  • DaRocha AB, Lopes RM, Schwartsmann G. Natural products in anticancer therapy. Curr Opin Pharmacol. 2001;1(4):364–9.

    Article  CAS  Google Scholar 

  • Febriansah R, Putri DDP, Sarmoko, Nurulita NA, Meiyanto E, Nugroho AE. Hesperidin as a preventive resistance agent in MCF-7 breast cancer cells line resistance to doxorubicin. Asian Pac J Trop Biomed. 2014;4(3):228–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985;39(4):783–91.

    Article  PubMed  Google Scholar 

  • Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004;47(7):1739–49.

    Article  CAS  PubMed  Google Scholar 

  • Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006;49(21):6177–96.

    Article  CAS  PubMed  Google Scholar 

  • Ganatra S H. Inhibition studies of naturally occurring terpene based compounds with cyclin-dependent kinase 2 enzyme. J Comput Sci Syst Biol. 2012;5(3):68–73.

    Article  CAS  Google Scholar 

  • Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem. 2004;47(7):1750–9.

    Article  CAS  PubMed  Google Scholar 

  • Hillman GG. Dietary agents in cancer chemoprevention and treatment. J Oncol. 2012;21:209–19.

    Google Scholar 

  • Huang W, He T, Chai C, Yang Y, Zheng Y, Zhou P, Qiao X, Zhang B, Liu Z, Wang J, Shi C. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression. PLoS One. 2012;7(5):1–17.

    Google Scholar 

  • Jae YC, Park J. Contribution of natural inhibitors to the understanding of the PI3K/PDK1/PKB pathway in the insulin-mediated intracellular signaling cascade. Int J Mol Sci. 2008;9(11):2217–30.

    Article  CAS  Google Scholar 

  • Jorgensen WL, Duffy EM. Prediction of drug solubility from structure. Adv Drug Deliv Rev. 2002;54(3):355–66.

    Article  CAS  PubMed  Google Scholar 

  • Jorgensen WL, Tirado-Rives J. The OPLS potential functions for proteins. Energy minimizations for crystals of cyclic peptides and crambin. J Am Chem Soc. 1988;110(6):1657–66.

    Article  CAS  PubMed  Google Scholar 

  • Jorgensen WL, Maxwell DS, Tirado-Rives J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc. 1996;118(45):11225–36.

    Article  CAS  Google Scholar 

  • Kamaraj S, Ramakrishnan G, Anandakumar P, Jagan S, Devaki T. Antioxidant and anticancer efficacy of hesperidin in benzo(a)pyrene induced lung carcinogenesis in mice. Investig New Drugs. 2009;27(3):214–22.

    Article  CAS  Google Scholar 

  • Kim SK. Marine carbohydrates: fundamentals and applications. Oxford: Elsevier; 2014.

    Google Scholar 

  • Kishimoto H, Wang Z, Bhat-Nakshatri P, Chang D, Clarke R, Nakshatri H. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1α/CXCL12. Carcinogenesis. 2005;26(10):1706–15.

    Article  CAS  PubMed  Google Scholar 

  • Kumar S, Chashoo G, Saxena AK, Pandey AK. Parthenium hysterophorus: a probable source of anticancer, antioxidant and anti-HIV agents. Biomed Res Int. 2013;2013:1–11.

    Google Scholar 

  • Lauria A, Ippolito M, Almerico AM. Inside the Hsp90 inhibitors binding mode through induced fit docking. J Mol Graph Model. 2009;27(6):712–22.

    Article  CAS  PubMed  Google Scholar 

  • Lee CJ, Wilson L, Jordan MA, Nguyen V, Tang J, Smiyun G. Hesperidin suppressed proliferations of both human breast cancer and androgen-dependent prostate cancer cells. Phytother Res. 2010;24(S1):S15–9.

    Article  PubMed  Google Scholar 

  • Lee J-C, Hou M-F, Huang H-W, Chang F-R, Yeh C-C, Tang J-Y, Chang HW. Marine algal natural products with anti-oxidative, anti-inflammatory, and anti-cancer properties. Cancer Cell Int. 2013;13(1):1–7.

    Article  CAS  Google Scholar 

  • Liao L, Chen X, Wang S, Parlow AF, Xu J. Steroid receptor coactivator 3 maintains circulating insulin-like growth factor I (IGF-I) by controlling IGF-binding protein 3 expression. Mol Cell Biol. 2008;28(7):2460–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lu JJ, Crimin K, Goodwin JT, Crivori P, Orrenius C, Xing L, Tandler PJ, Vidmar TJ, Amore BM, Wilson AG, Stouten PF. Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat. J Med Chem. 2004;47(24):6104–7.

    Article  CAS  PubMed  Google Scholar 

  • Luo H, Rankin GO, Liu L, Daddysman MK, Jiang BH, Chen YC. Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutr Cancer. 2009;61(4):554–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mayer AMS, Gustafson KR. Marine pharmacology in 2001-2: anti-tumour and cytotoxic compounds. Eur J Cancer. 2004;40(18):2676–704.

    Article  CAS  PubMed  Google Scholar 

  • Mayer AMS, Gustafson KR. Marine pharmacology in 2003–2004: anti-tumour and cytotoxic compounds. Eur J Cancer. 2006;42(14):2241–70.

    Article  CAS  PubMed  Google Scholar 

  • Mayer AMS, Gustafson KR. Marine pharmacology in 2005–2006: antitumour and cytotoxic compounds. Eur J Cancer. 2009;44(16):2357–87.

    Article  CAS  Google Scholar 

  • Moussavou G, Kwak DH, Obiang-Obonou BW, Maranguy CAO, Dinzouna-Boutamba SD, Lee DH, Pissibanganga OG, Ko K, Seo JI, Choo YK. Anticancer effects of different seaweeds on human colon and breast cancers. Mar Drugs. 2014;12(9):4898–911.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Muthuirulappan S, Francis SP. Anti-cancer mechanism and possibility of nano-suspension formulation for a marine algae product fucoxanthin. Asian Pac J Cancer Prev. 2013;14(4):2213–6.

    Article  PubMed  Google Scholar 

  • Oh A. The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells. Cancer Res. 2014;64:8299–308.

    Article  Google Scholar 

  • Phosrithong N, Ungwitayatorn J. Molecular docking study on anticancer activity of plant-derived natural products. Med Chem Res. 2010;19(8):817–35.

    Article  CAS  Google Scholar 

  • Qin L, Wu Y, Toneff MJ, Li D, Liao L, Gao X, Bane FT, Tien JC, Xu Y, Feng Z, Yang Z. NCOA1 directly targets M-CSF1 expression to promote breast cancer metastasis. Cancer Res. 2015a;74(13):3477–88.

    Article  CAS  Google Scholar 

  • Qin L, Xu Y, Xu Y, Ma G, Liao L, Wu Y, Li Y, Wang X, Wang X, Jiang J, Wang J. NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1alpha- and AP-1-mediated VEGFa transcription. Oncotarget. 2015b;6(27):23890–904.

    Article  PubMed  PubMed Central  Google Scholar 

  • Razeto A, Ramakrishnan V, Litterst CM, Giller K, Griesinger C, Carlomagno T, Lakomek N, Heimburg T, Lodrini M, Pfitzner E, Becker S. Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain. J Mol Biol. 2004;336(2):319–29.

    Article  CAS  PubMed  Google Scholar 

  • Roell D, Baniahmad A. The natural compounds atraric acid and N-butylbenzene-sulfonamide as antagonists of the human androgen receptor and inhibitors of prostate cancer cell growth. Mol Cell Endocrinol. 2011;332(1–2):1–8.

    Article  CAS  PubMed  Google Scholar 

  • Sarkar FH, Li Y. Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res. 2006;66(7):3347–50.

    Article  CAS  PubMed  Google Scholar 

  • Sawadogo W, Schumacher M, Teiten MH, Cerella C, Dicato M, Diederich M. A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2011. Molecules. 2013;18(4):3641–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sawadogo WR, Boly R, Cerella C, Teiten MH, Dicato M, Diederich M. A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2012. Molecules. 2015;20(4):7097–142.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shivakumar D, Williams J, Wu Y, Damm W, Shelley J, Sherman W. Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field. J Chem Theory Comput. 2010;6(5):1509–19.

    Article  CAS  PubMed  Google Scholar 

  • Singh P, Bast F. In silico molecular docking study of natural compounds on wild and mutated epidermal growth factor receptor. Med Chem Res. 2014a;23(12):5074–85.

    Article  CAS  Google Scholar 

  • Singh P, Bast F. Multitargeted molecular docking study of plant-derived natural products on phosphoinositide-3 kinase pathway components. Med Chem Res. 2014b;23(4):1690–700.

    Article  CAS  Google Scholar 

  • Singh P, Bast F. High-throughput virtual screening, identification and in vitro biological evaluation of novel inhibitors of signal transducer and activator of transcription 3. Med Chem Res. 2015a;24(6):2694–708.

    Article  CAS  Google Scholar 

  • Singh P, Bast F. Screening and biological evaluation of myricetin as a multiple target inhibitor insulin, epidermal growth factor, and androgen receptor; In silico and in vitro. Investig New Drugs. 2015b;33(3):575–93.

    Article  CAS  Google Scholar 

  • Singh P, Bast F. Screening of multi-targeted natural compounds for receptor tyrosine kinases inhibitors and biological evaluation on cancer cell lines, in silico and in vitro. Med Oncol. 2015c;32(9):1–18.

    CAS  Google Scholar 

  • Singh P, Alex JM, Bast F. Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer. Med Oncol. 2014;31(1):1–14.

    Article  CAS  Google Scholar 

  • Tien JC, Liu Z, Liao L, Wang F, Xu Y, Wu YL, Zhou N, Ittmann MM, Xu J. The steroid receptor coactivator-3 is required for the development of castration-resistant prostate cancer. Cancer Res. 2013;73(13):3997–4008.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tien JCY, Liao L, Liu Y, Liu Z, Lee DK, Wang F, Xu J. The steroid receptor coactivator-3 is required for developing neuroendocrine tumor in the mouse prostate. Int J Biol Sci. 2014;10(10):1116–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vallianatou T, Lambrinidis G, Tsantili-Kakoulidou A. In silico prediction of human serum albumin binding for drug leads. Expert Opin Drug Discov. 2013;8(5):583–95.

    Article  CAS  PubMed  Google Scholar 

  • Vlachos IS, Zagganas K, Paraskevopoulou MD, Georgakilas G, Karagkouni D, Vergoulis T, Dalamagas T, Hatzigeorgiou AG. DIANA-miRPath v3. 0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015;43(W1):W460–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang H, Gao M, Wang J. Kaempferol inhibits cancer cell growth by antagonizing estrogen-related receptor α and ϒ activities. Cell Biol Int. 2013;37(11):1190–6.

    CAS  PubMed  Google Scholar 

  • Xu J, Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol. 2003;17:1681–92.

    Article  CAS  PubMed  Google Scholar 

  • Xu J, Wu R-C, O’Malley BW. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer. 2009;9(9):615–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgment

PS and PPK acknowledge Indian Council of Medical Research (ICMR), India and UGC-CSIR, India respectively for providing the financial assistance in the form of Postdoc and Junior Research Fellowship. SK acknowledges the Central University of Punjab for providing infrastructure facilities.

Author information

Authors and Affiliations

  1. Tumor Biology Laboratory, National Institute of Pathology, New Delhi, India

    Pushpendra Singh

  2. Department of Biochemistry and Microbial Sciences, Central University of Punjab, Bathinda, Punjab, India

    Prem P. Kushwaha, Atul K. Singh & Shashank Kumar

Authors
  1. Pushpendra Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prem P. Kushwaha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Atul K. Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shashank Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Biochemistry and Microbial Sciences, Central University of Punjab, Bathinda, Punjab, India

    Shashank Kumar

  2. Department of Biochemistry, Chukwuemeka Odumegwu Ojukwu University, Uli, Anambra, Nigeria

    Chukwuebuka Egbuna

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Singh, P., Kushwaha, P.P., Singh, A.K., Kumar, S. (2019). Association Between Nuclear Receptor Coactivator 1 and Stem Cell Signaling Pathway and Identification of Natural NCOA1 Inhibitors: An in-silico Study. In: Kumar, S., Egbuna, C. (eds) Phytochemistry: An in-silico and in-vitro Update. Springer, Singapore. https://doi.org/10.1007/978-981-13-6920-9_30

Download citation

Publish with us

Policies and ethics

Search

Navigation